Form 4: Zivo Bioscience Director Buys 2,777 Shares at $9

Laith L. Yaldoo, a Director and 10% Owner of Zivo Bioscience, Inc., acquired 2,777 shares of common stock at $9 per share.

Summary

• Laith L. Yaldoo, a Director and 10% Owner of Zivo Bioscience, Inc. (ZIVO), purchased 2,777 shares of common stock.
• The transaction occurred on November 28, 2025, at a price of $9 per share.
• Following this transaction, Mr. Yaldoo indirectly beneficially owns 577,872 shares of common stock through HEP Investments LLC.
• The purchase was made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 7

Explanation: The sentiment is positive due to significant insider buying by a director and 10% owner, indicating confidence in the company's valuation and future prospects.

Positives

• A Director and 10% Owner, Laith L. Yaldoo, increased his stake in Zivo Bioscience, Inc. by acquiring 2,777 shares.
• Insider buying can signal confidence in the company's future prospects and valuation at the current price of $9 per share.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Laith L. Yaldoo, a Director and 10% Owner, acquired shares, which constitutes an insider transaction.

Stakeholder Impact

• Shareholders may view the insider purchase as a positive indicator of management's belief in the company's value, potentially boosting investor confidence.

Key Dates

Recommendation

The purchase of common stock by a Director and 10% Owner, Laith L. Yaldoo, signals strong insider confidence in Zivo Bioscience, Inc. at the current share price. Such insider buying often precedes positive company developments or reflects a belief that the stock is undervalued, making it a favorable signal for potential investors.

Keywords

Zivo Bioscience, ZIVO, Insider Trading, Form 4, Stock Purchase, Director, 10% Owner, Equity Acquisition, Rule 10b5-1